Come on Jackie.
With the March rebalancing ASX300 on the cards we need some credible news.
Some dates on Mundipharma and Aspen Vivagel BV release would be enough. Since SPL is controlling production of the product you must have some knowledge about supply and have some indication of the dates of product launch. This assumption is based on the fact that you have orders for the product from both parties.
SPL dropping out of the ASX300 would have a devastating effect on the share price. look at the effect from the examples of companies dropping out of the ASX300 I provided earlier.
Many Australian super funds only allow trading for ASX300 stocks. So the absence of retail buyers of our stock will be a shorter's paradise.
Your are supposed to be looking after shareholders interest.
Some news Please.
cheers Lies
asx 300 rebalancing SPL risk, page-5
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
